Previous close | 2.2600 |
Open | 2.2700 |
Bid | 2.1000 x 600 |
Ask | 2.1300 x 600 |
Day's range | 2.0900 - 2.2790 |
52-week range | 1.8800 - 8.8000 |
Volume | |
Avg. volume | 307,761 |
Market cap | 104.205M |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Akoya Biosciences will host its Annual General Meeting on 4th of June Salary of US$542.5k is part of CEO...
Despite a revenue dip, Akoya Biosciences showcases growth in reagent sales and strategic expansions, setting a course for recovery.
Akoya (AKYA) delivered earnings and revenue surprises of -16.67% and 23.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?